Back
Supernus Pharmaceuticals Quote, Financials, Valuation and Earnings
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
38
SUPN
Supernus Pharmaceuticals
Last Price:
30.09
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.Supernus Pharmaceuticals Price Quote
$30.09
+0.03 (+0%)
(Updated: May 2, 2024 at 6:17 AM ET)
Supernus Pharmaceuticals Key Stats
Sell
38
Supernus Pharmaceuticals (SUPN)
is a Sell
Day range:
$29.99 - $30.69
52-week range:
$21.99 - $38.09
Dividend yield:
0%
P/E ratio:
1,503.00
P/S ratio:
2.81
P/B ratio:
1.79%
Volume:
348.1K
Avg. volume:
369.9K
1-year change:
-18.65%
Market cap:
$1.6B
Revenue:
$607.5M
EPS:
$-0
How Much Does Supernus Pharmaceuticals Make?
-
How Much Are Supernus Pharmaceuticals's Sales Annually?
SUPN Revenues are $607.5M -
How Much Profit Does Supernus Pharmaceuticals's Make A Year?
SUPN net income is $1.3M
Is Supernus Pharmaceuticals Growing As A Company?
-
What Is Supernus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.02% -
What Is Supernus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.96%
Supernus Pharmaceuticals Stock Price Performance
-
Did Supernus Pharmaceuticals Stock Go Up Last Month?
Supernus Pharmaceuticals share price went down by -10.32% last month -
Did SUPN's Share Price Rise Over The Last Year?
SUPN share price fell by -18.65% over the past 1 year
What Is Supernus Pharmaceuticals 52-Week High & Low?
-
What Is Supernus Pharmaceuticals’s 52-Week High Share Price?
Supernus Pharmaceuticals has traded as high as $38.09 over the past 52 weeks -
What Is Supernus Pharmaceuticals’s 52-Week Low Share Price?
Supernus Pharmaceuticals has traded as low as $21.99 over the past 52 weeks
Supernus Pharmaceuticals Price To Free Cash Flow
-
Is Supernus Pharmaceuticals Stock Overvalued?
Supernus Pharmaceuticals is trading at a price to free cash flow ratio of 15.42 -
Is Supernus Pharmaceuticals Stock Undervalued?
Supernus Pharmaceuticals EV to Free Cash Flow ratio is 12.58 -
What Is Supernus Pharmaceuticals’s Price Earnings Growth Ratio?
SUPN PEG ratio is 0.00 -
Is Supernus Pharmaceuticals Trading At A Premium To Earnings?
Supernus Pharmaceuticals EV to EBIT ratio is 268.22
Is It Risky To Buy Supernus Pharmaceuticals?
-
How Much Debt Does Supernus Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Supernus Pharmaceuticals Have?
Cash and short term investments quarterly total is $254.9M -
What Is Supernus Pharmaceuticals’s Book Value Per Share?
Book value per share is 16.84
Is Supernus Pharmaceuticals Cash Flow Positive?
-
What Is SUPN Cash Flow From Operations?
Cash flow from operations (TTM) is $111.1M -
What Is Supernus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$397.9M -
What Is Supernus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $268.7M
Supernus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SUPN return on invested capital is 0.12% -
What Is Supernus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 0.09% -
What Is SUPN Return On Equity?
ROE is a measure of profitability and is 0.15%
Supernus Pharmaceuticals Earnings Date & Stock Price
-
What Is Supernus Pharmaceuticals's Stock Price Today?
A single share of SUPN can be purchased today for 30.06 -
What Is Supernus Pharmaceuticals’s Stock Symbol?
Supernus Pharmaceuticals trades on the nasdaq under the ticker symbol: SUPN -
When Is Supernus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Supernus Pharmaceuticals is scheduled on May 8, 2024 -
When Is SUPN's next ex-dividend date?
Supernus Pharmaceuticals's next ex-dividend date is May 7, 2020 -
How To Buy Supernus Pharmaceuticals Stock?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Supernus Pharmaceuticals Competitors
-
Who Are Supernus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Supernus Pharmaceuticals or are related in some way:
Supernus Pharmaceuticals Dividend Yield
Data Unavailable
Supernus Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -95.95% | 61.03% |
| Revenue: | -1.8% | 5.99% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 40.33 |
| Upside from Last Price: | 34.18% |